个人简介
受教育经历
2003.9–2006.6, 华中科技大学同济医学院, 妇产科学, 博士
2000.9–2003.7, 华中科技大学同济医学院, 妇产科学, 硕士
1990.9–1995.7, 河南医科大学, 儿科医学, 学士, 导师:
工作经历
2012.7–2013.9, 美国亚利桑那医学中心, 妇产科系 病理系, 访问学者
2006.6–至今, 河南大学, 河南省人民医院, 主任医师
1995.8–2000.8, 河南大学, 第一附属医院, 主治医师
奖励
1 卵巢高级别浆液性癌早期诊治的临床与基础研究 2017 河南省卫生厅 一等奖 第一名
2 卵巢高级别浆液性癌早期诊治的临床应用 2017 河南省科技厅 二等奖 第一名
近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Wang Y, Hong S, Mu J, Wang Y, Lea L, Kong B, Zheng W. Tubal Origin of (Ovarian) Low-Grade Serous Carcinoma:A Gene Expression Profile Study. J Oncology. 2019
Wang Y, Chen H, Zhao M, Fadare O, Zheng W. Primary Ovarian Pregnancy: A Case Series and Analysis. Int J Gynecol Pathol. 2019 Jan;38(1):85-91.
Li YJ, Wang Y, Wang Y. MicroRNA‐99bsuppresseshumancervicalcancercellactivity by inhibiting the PI3K/AKT/mTOR signaling pathway. J Cell Physiol. 2019 Jun;234(6):9577-9591.
Yang L, Lv Q , Chen W, Sun J, Wu Y, Wang Y, Chen X, Chen X, Zhang Z. Presence of embryonic DNA in culture medium. Oncotaget.2017 Jun 29;8(40):67805-67809.
Chen H, Klein R, Arnold S, Wang Y, Chambers S, Zheng W. Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection. J Vis Exp. 2017 Jul 25;(125).
Wang Y, Wang Y, Wei L, Hong S, Zhao M, Zhang X, Zheng W*. BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions. J Ovarian Res. 2017;10 (1): 12. doi: 10.1186/s13048-017-0307-6. PMID: 28270171
Fan R, Wang Y, Wang Y, Wei L, Zheng W. Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-survivin pathway. Am J Transl Res. 2017 Mar 15;9(3):1483-1491.
Li L, Wang X, Park JY, Chen H, Wang Y, Zheng W. Pathological Findings of Explanted Vaginal Mesh. Human Pathology, 2017 Nov;69:46-54.
Wang Y, Wang Y, Zhang Z*, Park JY, Guo D, Liao H, Yi X, Zheng Y, Zhang D, Chambers SK, Zheng W*.Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway,Oncotarget,2016,7(9):10363-10372
Wang Y, Li L, Wang Y, Tang SN, Zheng W*. Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis, Am J Transl Res,2015 Oct 15;7(10):2082-90
Wang Y, Mang M, Wang Y, Wang L, Klein R, Kong B, Zheng W*. Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma, Am J Cancer Res,2015 Feb 15;5(3):869-79
Wang Y, Wang Y, Li D, Li L, Zhang W, Yao G, Jiang Z, Zheng W*. IMP3 signatures of fallopian tube: a risk for pelvic serous cancers,J Hematol Oncol,2014, 7(1) :49
Wang Y, Li L, Wang Y, Yuan Z, Zhang W, Hatch KD, Zheng W*. IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis, J Exp Clin Cancer Res,2014, 33(1): 60
Wang Y, Wang Y, Zheng W*.Cytologic changes of ovarian epithelial cancer induced by neoadjuvant chemotherapy,Int J Clin Exp Pathol, 2013 Sep 15;6(10):2121-8
Wang Y, Wang Y, Ning Y, Kong B, Zheng W. Lynch syndrome related endometrial cacer: aspects and concerns, Progress in Obstetrics & Gynecology, 2013(7):523-526
Wang Y#, Wang Y#, Li J, Yuan Z, Yuan B, Zhang T, Cragun JM, Kong B, Zheng W*. PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy, J Hematol Oncol,2013 Aug 19;6:60
Wang Y#, Wang Y#, Li J, Cragun J, Hatch K, Chambers SK, Zheng W*.Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium, J Hematol Oncol, 2013 Mar 25;6:22
Jia L, Yuan Z, Wang Y, Cragun JM, Kong B, Zheng W. Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma, Mod Pathol,2014 Jun,13
Yuan Z, Wang L, Wang Y, Zhang T, Li L, Cragun JM, Chambers SK, Kong B, Zheng W. Tubal origin of ovarian endometriosis. Mod Pathol,2014 Jan,3
Yuan Z, Wang Y, Cragun JM, Chambers SK, Zheng W: Cell origin of endometriosis: contribution by the fallopian tube epithelium. Am J Clin Exp Obstet Gynecol,2013,1:37-42
京公网安备 11010802027423号